Loading patent…
OwnerLaetitia FONTAINE, Aline LARDINOIS +3inventors
InventorsLaetitia FONTAINE, Aline LARDINOIS, Houssein CHALHOUB, Françoise VAN BAMBEKE, Albert RUIZ-SORRIBAS
Estimating the term…
A parapharmaceutical or pharmaceutical composition is administrable to living beings, and in particular to human beings. The composition includes at least one endoribonuclease enzyme chosen from the EC 3.1.30 and EC 3.1.31 classes, preferably in a content of from 10 to 1000 U/ml, preferably 50 to 500 U/ml, preferably from 100 to 500 U/ml. The composition is for curative or preventive treatment for dermatological infections or for infections which develop on superficial or deep burns and wounds.
A method of treatment with a parapharmaceutical or pharmaceutical composition, the parapharmaceutical or pharmaceutical composition comprising at least one endoribonuclease enzyme selected from the group consisting of enzymes belonging to the enzyme classes EC 3.1.30 and EC 3.1.31 and mixtures thereof, to potentiate a microbicidal agent, comprising an antibiotic, an antifungal, or a disinfectant, the method comprising administering a therapeutically effective dose of the parapharmaceutical or pharmaceutical composition to human beings in the treatment and/or the prevention of bacterial infections involving biofilm formation.
Parapharmaceutical or pharmaceutical composition for administration to human beings, comprising at least one endoribonuclease enzyme selected from classes EC 3.1.30 and EC 3.1.31, at a concentration of 10 to 1000 U/ml.
A non-therapeutic method of using subtilisin (EC.3.4.21.62) comprising potentiating one or more anti-microbiological molecules for a biofilm comprising Candida albicans.
Pharmaceutical composition comprising subtilisin (EC.3.4.21.62) for the treatment of a biofilm comprising Candida albicans, said biofilm affecting a patient.
Dependencies are inferred from the claim text.